- Home
- TNGX vs MBUU Comparison
TNGX vs MBUU Comparison
Compare TNGX & MBUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- MBUU
- Stock Information
- Founded
- TNGX 2014
- MBUU 1982
- Country
- TNGX United States
- MBUU United States
- Employees
- TNGX N/A
- MBUU N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- MBUU Marine Transportation
- Sector
- TNGX Health Care
- MBUU Industrials
- Exchange
- TNGX Nasdaq
- MBUU Nasdaq
- Market Cap
- TNGX 723.2M
- MBUU 633.5M
- IPO Year
- TNGX N/A
- MBUU 2014
- Fundamental
- Price
- TNGX $8.76
- MBUU $32.72
- Analyst Decision
- TNGX Strong Buy
- MBUU Hold
- Analyst Count
- TNGX 6
- MBUU 6
- Target Price
- TNGX $10.00
- MBUU $33.60
- AVG Volume (30 Days)
- TNGX 2.1M
- MBUU 168.5K
- Earning Date
- TNGX 11-06-2025
- MBUU 10-30-2025
- Dividend Yield
- TNGX N/A
- MBUU N/A
- EPS Growth
- TNGX N/A
- MBUU N/A
- EPS
- TNGX N/A
- MBUU 0.76
- Revenue
- TNGX $24,296,000.00
- MBUU $807,561,000.00
- Revenue This Year
- TNGX $20.42
- MBUU N/A
- Revenue Next Year
- TNGX N/A
- MBUU $8.01
- P/E Ratio
- TNGX N/A
- MBUU $43.38
- Revenue Growth
- TNGX N/A
- MBUU N/A
- 52 Week Low
- TNGX $1.03
- MBUU $24.43
- 52 Week High
- TNGX $9.70
- MBUU $47.82
- Technical
- Relative Strength Index (RSI)
- TNGX 58.17
- MBUU 56.76
- Support Level
- TNGX $8.85
- MBUU $28.40
- Resistance Level
- TNGX $9.31
- MBUU $31.06
- Average True Range (ATR)
- TNGX 0.56
- MBUU 1.04
- MACD
- TNGX 0.08
- MBUU 0.32
- Stochastic Oscillator
- TNGX 67.60
- MBUU 90.38
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About MBUU Malibu Boats Inc.
Malibu Boats is a leading designer and manufacturer of power boats in the United States. It is a top manufacturer of performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a leading producer of sterndrive boats in the US in the 24- to 29-foot segment, in 2017, and Pursuit Boats, which makes high-end offshore and outboard motorboats, in 2018. In 2021, it purchased Maverick Boat Group, a top seller of flat fishing boats, including bay, dual-console, and center-console boats. Malibu has also expanded into boat trailers and accessories, and in 2020 began producing its own engines (Monsoon) for its performance sport boats and now for Cobalt. Malibu's target market includes a wide range of water enthusiasts who embrace the active outdoor lifestyle.